D
Dennis Deapen
Researcher at University of Southern California
Publications - 205
Citations - 16417
Dennis Deapen is an academic researcher from University of Southern California. The author has contributed to research in topics: Breast cancer & Population. The author has an hindex of 63, co-authored 200 publications receiving 13902 citations. Previous affiliations of Dennis Deapen include University of Michigan & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Correlates of local therapy for women with DCIS
Steven J. Katz,Paula M. Lantz,Nancy K. Janz,Angela Fagerlin,Kendra Schwartz,Lihua Liu,Dennis Deapen,Monica Morrow +7 more
TL;DR: A population-based survey of women with DCIS to address correlates of local treatment decisions with regard to clinical factors, characteristics of patient-surgeon communication, and patient attitudes and results showed low rates of radiation therapy after BCS suggest under-treatment.
Journal ArticleDOI
Oral Contraceptive, Menopausal Hormone Therapy Use and Risk of non-Hodgkin Lymphoma in the California Teachers Study
Yani Lu,Jane Sullivan-Halley,Katherine D. Henderson,Huiyan Ma,Lei Duan,Sophia S. Wang,James V. Lacey,Ellen T. Chang,Dennis Deapen,Leslie R. Bernstein +9 more
TL;DR: Evaluated data suggest that ET use decreases the risk of B-cell NHL among women with both ovaries removed, but not among women retaining at least part of an ovary remaining.
Proceedings ArticleDOI
Abstract 867: Oral contraceptive, menopausal hormone therapy use and risk of B-cell non-Hodgkin lymphoma in the California Teachers Study
Yani Lu,Jane Sullivan-Halley,Katherine D. Henderson,Huiyan Ma,Lei Duan,Sophia S. Wang,James V. Lacey,Ellen T. Chang,Dennis Deapen,Leslie Bernstein +9 more
TL;DR: Evaluated data suggest that ET use decreases the risk of B-cell NHL among women with both ovaries removed, but not among women retaining at least part of an ovary remaining.
Journal ArticleDOI
Cancer surveillance and preventive services in a diverse sample of breast and colorectal cancer survivors.
Beth A. Glenn,Narissa J Nonzee,Ann S. Hamilton,Lina Tieu,Annette E. Maxwell,Catherine M. Crespi,L. Cindy Chang,Dennis Deapen,Roshan Bastani +8 more
TL;DR: Efforts are needed to address gaps in the use of recommended cancer screening and preventive health services among cancer survivors, particularly survivors with early-onset disease who may be at increased risk for additional cancers and common chronic conditions over their lifetime.
Journal ArticleDOI
Association of Genetic Testing Results with Mortality Among Women with Breast Cancer or Ovarian Cancer
Allison W. Kurian,Paul Abrahamse,Irina Bondarenko,Ann S. Hamilton,Dennis Deapen,Scarlett Lin Gomez,Monica Morrow,Jonathan S. Berek,Timothy P. Hofer,Steven J. Katz,Kevin C. Ward +10 more
TL;DR: In this article, the authors examined the association of genetic results with cancer-specific mortality in 22,495 breast and 4,320 ovarian cancer patients with a median follow-up of 41 months.